Long-Term Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma.
ESD
long-term outcomes
superficial esophageal cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
02 Oct 2020
02 Oct 2020
Historique:
received:
01
09
2020
revised:
26
09
2020
accepted:
29
09
2020
entrez:
7
10
2020
pubmed:
8
10
2020
medline:
8
10
2020
Statut:
epublish
Résumé
In this review, we summarize up-to-date reports with 5-year survival after endoscopic submucosal dissection (ESD) for superficial esophageal squamous cell carcinoma. In ESD for the depth of the epithelium (m1) or lamina propria (m2), the 5-year cause-specific survival and 5-year overall survival rates were reported to be 98-100%, and 85-95%, respectively. In cases with submucosal invasion or vascular involvement, additional prophylactic treatment such as chemoradiotherapy or surgery was recommended, and the 5-year cause-specific survival and 5-year overall survival rates were reported to be 85-100%, and 56-84%, respectively. Additional treatment might be too invasive for the elderly or patients with severe comorbidities. The risk of additional therapy should be balanced against the risk of lymph node metastasis, considering the life expectancy of such patients.
Identifiants
pubmed: 33023117
pii: cancers12102849
doi: 10.3390/cancers12102849
pmc: PMC7601175
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 20H036672
Références
Endosc Int Open. 2020 Jan;8(1):E20-E24
pubmed: 31921980
Gastrointest Endosc. 2009 Nov;70(5):860-6
pubmed: 19577748
Cancer. 2000 Jul 15;89(2):248-54
pubmed: 10918152
Endosc Int Open. 2019 Mar;7(3):E355-E360
pubmed: 30834294
PLoS One. 2017 Apr 6;12(4):e0175182
pubmed: 28384229
World J Gastroenterol. 2018 Apr 21;24(15):1632-1640
pubmed: 29686470
Clin Endosc. 2012 Nov;45(4):375-8
pubmed: 23251884
Dig Liver Dis. 2017 Apr;49(4):427-433
pubmed: 28096057
Endoscopy. 2018 Jul;50(7):662-670
pubmed: 29272907
Endoscopy. 2020 Nov;52(11):967-975
pubmed: 32583396
Dig Liver Dis. 2018 Nov;50(11):1255-1256
pubmed: 30224315
Gastrointest Endosc. 2018 Oct;88(4):624-633
pubmed: 29750981
Esophagus. 2019 Jan;16(1):25-43
pubmed: 30171414
Jpn J Clin Oncol. 2018 Jun 1;48(6):598-599
pubmed: 29697821
Gastrointest Endosc. 1999 Oct;50(4):560-3
pubmed: 10502182
Esophagus. 2019 Jan;16(1):1-24
pubmed: 30171413
Cancers (Basel). 2018 Aug 03;10(8):
pubmed: 30081489
Cancers (Basel). 2020 Jul 27;12(8):
pubmed: 32726927
World J Gastrointest Endosc. 2012 May 16;4(5):162-6
pubmed: 22624067
Esophagus. 2019 Jul;16(3):285-291
pubmed: 30937573
Clin Endosc. 2015 Jan;48(1):85-6
pubmed: 25674534
Surg Endosc. 1990;4(4):198-201
pubmed: 2291159
Endoscopy. 2015 Sep;47(9):775-83
pubmed: 25826277
Gastrointest Endosc. 2018 Apr;87(4):1079-1084
pubmed: 29122603
Dig Endosc. 2015 Jan;27(1):8-15
pubmed: 25369736
Endoscopy. 2018 Sep;50(9):839-845
pubmed: 29548040
Cancers (Basel). 2020 Jun 16;12(6):
pubmed: 32560226
Dig Endosc. 2014 Nov;26(6):701-6
pubmed: 25115459
Endoscopy. 2017 Oct;49(10):E227-E228
pubmed: 28759932
Dis Esophagus. 2018 Jul 1;31(7):
pubmed: 29982386
Endoscopy. 2015 Apr;47(4):336-40
pubmed: 25314328
Gut Liver. 2014 Nov;8(6):612-8
pubmed: 25368748
Clin Transl Gastroenterol. 2020 Jul;11(7):e00193
pubmed: 32675704
Curr Opin Gastroenterol. 2017 Sep;33(5):315-319
pubmed: 28704212
Gastrointest Endosc. 2017 Nov;86(5):913-914
pubmed: 28576395
Cancers (Basel). 2020 Aug 04;12(8):
pubmed: 32759723
Asian Pac J Cancer Prev. 2014;15(4):1803-6
pubmed: 24641412
Clin Gastroenterol Hepatol. 2005 Jul;3(7 Suppl 1):S67-70
pubmed: 16013002
Endosc Int Open. 2019 Jun;7(6):E764-E770
pubmed: 31157294
Endoscopy. 2015 Sep;47(9):829-54
pubmed: 26317585
Endoscopy. 2006 Feb;38(2):149-56
pubmed: 16479422
Endoscopy. 2009 Aug;41(8):661-5
pubmed: 19565442
Endoscopy. 2019 Apr;51(4):298-306
pubmed: 30261535
Gut Liver. 2018 Mar 15;12(2):119-124
pubmed: 28673068